Edgar V. Lerma 🇵🇭
banner
edgarvlermamd.bsky.social
Edgar V. Lerma 🇵🇭
@edgarvlermamd.bsky.social
Chicago Sports Fan... Nephrologist by day. My tweets are not medical advice. The views expressed here are my own and not those of my employer
Sibeprenlimab: First @fda.gov approved therapy targeting B cells which produce the abnormal antibodies responsible for #IgAN, addressing the fundamental cause
#Nephpearls #NephSky

#VisualAbstract by @nephroseeker.medsky.social

👉🏼 www.fda.gov/drugs/news-e...

👉🏼 pubmed.ncbi.nlm.nih.gov/41211929/
November 27, 2025 at 2:40 AM
Cholemic Nephropathy aka Cholemic Nephrosis aka Bile Acid/ Bile Cast Nephropathy ca. 2024
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38649215/
November 26, 2025 at 10:43 PM
Testing for the Best Biomarker 🧪 in IgA Nephropathy #IgAN ca. 2025 from @asnpublications.bsky.social
#Nephpearls

Editorial by Dr Richard Lafayette 👉 pubmed.ncbi.nlm.nih.gov/41066174/

#VisualAbstract by @hellokidneymd.bsky.social
👉 pubmed.ncbi.nlm.nih.gov/40924482/
November 16, 2025 at 4:02 AM
BAFF and APRIL represent pre-HIT 1 in #IgAN
#Nephpearls #NephSky

Antigen-driven immune activation within lymphoid tissues leads to the release of BAFF and APRIL, which bind to those receptors and promote B-cell survival and production of IgA

👉🏼 pubmed.ncbi.nlm.nih.gov/38362118/
November 15, 2025 at 8:36 AM
According to ChatGPT, the “four-hit” (or “4-hit”) hypothesis for IgA nephropathy #IgAN was first clearly articulated by Hitoshi Suzuki et al. in their 2011 J. Am. Soc. Nephrol. paper, “The pathophysiology of IgA nephropathy.”
#Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/21949093/
November 15, 2025 at 8:24 AM
Prevalence, Resource Utilization, and Economic Impact of Kidney Function and Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS) ca. 2025 from @juancarlosqvelez.bsky.social
#Nephpearls #FSGS #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41222995/
November 14, 2025 at 3:37 PM
#Nephmadness collectibles 2019-2025
Near Mint condition
#NephSky
November 12, 2025 at 3:59 PM
A Phase 3 Trial of Atacicept in Patients with IgA Nephropathy ca. 2025
#Nephpearls #KidneyWk #NephSky

#VisualAbstract by @nephroseeker.medsky.social @nephjc.bsky.social

👉🏼 pubmed.ncbi.nlm.nih.gov/41196369/
November 9, 2025 at 8:10 PM
Sibeprenlimab in IgA Nephropathy: Interim Analysis of a Phase 3 Trial ca. 2025
#Nephpearls #KidneyWk #NephSky

#VisualAbstract by @nephroseeker.medsky.social @nephjc.bsky.social

👉🏼 www.nejm.org/doi/full/10....
November 9, 2025 at 5:15 PM
My first #KidneyWk was the 33rd Annual Scientific Meeting (including Renal Week) of the American Society of Nephrology, October, 2000 -- Toronto, Ontario, Canada 🇨🇦
#NephSky
November 9, 2025 at 5:03 PM
Your Legacy at #KidneyWk and around the world
#NephSky 🇵🇭🇺🇸
November 9, 2025 at 2:59 AM
It’s been a pleasure reconnecting with my mentors from @nu-nephrology.bsky.social Drs Daniel Batlle and Robert Rosa
#KidneyWk #NephSky

🙏🏽 I am forever grateful for their mentorship

✍🏼 My first ever publications were with them

pubmed.ncbi.nlm.nih.gov/11689388/

pubmed.ncbi.nlm.nih.gov/15327401/
November 8, 2025 at 2:05 PM
Indications for mineralocorticoid receptor antagonists (MRAs) in the management of cardio-kidney risk
#KidneyWk #Nephpearls #NephSky #Cardiorenal

✅ Check out this resource from @theisn.org
@isnkidneycare.bsky.social

👉 www.theisn.org/initiatives/...
November 8, 2025 at 12:46 PM
Which patients should be on SGLT2 inhibitors (SGLT2i) ⁉️

✅ Check out the SGLT2i Cold 🥶 Map from @theisn.org
#KidneyWk #Nephpearls

👉🏼 www.theisn.org/initiatives/...
November 8, 2025 at 12:04 PM
Immunosuppression in Older Kidney Transplant Recipients: A Randomized Controlled Trial ca. 2025 from @asnpublications.bsky.social
#Nephpearls #KidneyWk #NephSky

journals.lww.com/jasn/fulltex...
November 7, 2025 at 7:04 PM
Is It Time to Consider Population-Based Urine Dipstick Screening for Early Detection of Kidney Disease? ca. 2025 from @kireports.bsky.social @saynanorouzi.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 www.kireports.org/article/S246...
November 7, 2025 at 2:58 PM
CONFIDENCE (Post hoc): Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both ca. 2025 from
@asnpublications.bsky.social
#Nephpearls #KidneyWk #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41196655/
November 7, 2025 at 1:41 PM
We’re on a mission from God to save kidneys
#KidneyWk #TeamRodbyLerma #NephSky
November 7, 2025 at 12:00 AM
ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives ca. 2025 from @asnpublications.bsky.social
#Nephpearls #KidneyWk #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/40965988/
November 6, 2025 at 8:32 PM
You are with us in spirit @hswapnil.medsky.social
#KidneyWk #NephSky
November 5, 2025 at 10:59 PM
I made it to the big board #KidneyWk
Level Up ⬆️🆙
#NephSky
November 5, 2025 at 10:58 PM
Trying to catch up with IgA Nephropathy trials⁉️

Check out ✅ “IgAN: An Overview of the Clinical Trials” ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky #KidneyWk #IgAN

👉 pubmed.ncbi.nlm.nih.gov/41050133/
November 5, 2025 at 2:17 PM
B cells undergo a sequential process of maturation and selection and play a crucial role in the adaptive immune system by generating antibodies as a response to foreign antigens
#Nephpearls #KidneyWk #IgAN #NephSky

👉 pubmed.ncbi.nlm.nih.gov/38362118/
November 5, 2025 at 1:37 PM